316 related articles for article (PubMed ID: 31077056)
1. Pathological findings of progressive renal involvement in a patient with TAFRO syndrome.
Saito H; Tanaka K; Fujiwara M; Iwasaki T; Numata T; Oda A; Kanno M; Tanaka M; Eiro M; Satoh M; Kazama JJ
CEN Case Rep; 2019 Nov; 8(4):239-245. PubMed ID: 31077056
[TBL] [Abstract][Full Text] [Related]
2. TAFRO syndrome as a cause of glomerular microangiopathy: a case report and literature review.
Nagayama Y; Yamano M; Yagame M; Nariyama T; Takahashi M; Kawamoto M; Matsui K
BMC Nephrol; 2019 Oct; 20(1):375. PubMed ID: 31623576
[TBL] [Abstract][Full Text] [Related]
3. Thrombotic microangiopathy on kidney biopsy in a patient with TAFRO syndrome.
Ozeki T; Tsuji M; Yamamoto J; Shigematsu C; Maruyama S
CEN Case Rep; 2018 Nov; 7(2):243-247. PubMed ID: 29766467
[TBL] [Abstract][Full Text] [Related]
4. Renal Pathologic Findings in TAFRO Syndrome: Is There a Continuum Between Thrombotic Microangiopathy and Membranoproliferative Glomerulonephritis? A Case Report and Literature Review.
Leurs A; Gnemmi V; Lionet A; Renaud L; Gibier JB; Copin MC; Hachulla E; Hatron PY; Launay D; Fajgenbaum D; Terriou L
Front Immunol; 2019; 10():1489. PubMed ID: 31316523
[No Abstract] [Full Text] [Related]
5. Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature.
Zhou Q; Zhang Y; Zhou G; Zhu J
BMC Nephrol; 2020 Nov; 21(1):499. PubMed ID: 33225930
[TBL] [Abstract][Full Text] [Related]
6. Multicentric Castleman's disease associated with glomerular microangiopathy and MPGN-like lesion: does vascular endothelial cell-derived growth factor play causative or protective roles in renal injury?
Seida A; Wada J; Morita Y; Baba M; Eguchi J; Nishimoto N; Okino T; Ichimura K; Yoshino T; Makino H
Am J Kidney Dis; 2004 Jan; 43(1):E3-9. PubMed ID: 14712466
[TBL] [Abstract][Full Text] [Related]
7. TAFRO syndrome with renal biopsy successfully treated with steroids and cyclosporine: a case report.
Iwasaki T; Mizusaki K; Masumoto M; Minagawa Y; Azuma K; Furukawa T; Yoshida M; Kuragano T
BMC Nephrol; 2022 Jul; 23(1):262. PubMed ID: 35870879
[TBL] [Abstract][Full Text] [Related]
8. An autopsy case of TAFRO syndrome with membranoproliferative glomerulonephritis-like lesions.
Hashimoto K; Sano T; Honma Y; Ida M; Tominaga H; Sawada A; Abe T; Takahashi H; Shimada Y; Masaki T; Kamata M; Naito S; Aoyama T; Takeuchi Y; Akiya M; Inukai M; Nakata N
CEN Case Rep; 2019 Feb; 8(1):48-54. PubMed ID: 30244358
[TBL] [Abstract][Full Text] [Related]
9. A case of TAFRO syndrome, a variant of multicentric Castleman's disease, successfully treated with corticosteroid and cyclosporine A.
Takasawa N; Sekiguchi Y; Takahashi T; Muryoi A; Satoh J; Sasaki T
Mod Rheumatol; 2019 Jan; 29(1):198-202. PubMed ID: 27413814
[TBL] [Abstract][Full Text] [Related]
10. Complete resolution of TAFRO syndrome (thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly) after immunosuppressive therapies using corticosteroids and cyclosporin A : a case report.
Inoue M; Ankou M; Hua J; Iwaki Y; Hagihara M; Ota Y
J Clin Exp Hematop; 2013; 53(1):95-9. PubMed ID: 23801140
[TBL] [Abstract][Full Text] [Related]
11. Siltuximab Monotherapy in Tafro Syndrome: A Case Report and Review of the Literature.
Cordero L; Aguilar-Rodríguez F; Sandino J; Alonso M; Gutiérrez E
J Nephrol; 2023 May; 36(4):1181-1185. PubMed ID: 36652167
[TBL] [Abstract][Full Text] [Related]
12. Renal histological continuum of TAFRO syndrome: A case report and literature review.
Uemura T; Matsui M; Kokubu M; Samejima KI; Tsuruya K
Clin Nephrol; 2022 Feb; 97(2):121-128. PubMed ID: 34854374
[TBL] [Abstract][Full Text] [Related]
13. Unexplained cause of thrombocytopenia, fever, anasarca and hypothyroidism: TAFRO syndrome with thrombotic microangiopathy renal histology.
Simeni Njonnou SR; Deuson J; Royer-Chardon C; Vandergheynst FA; Wilde V
BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32606113
[TBL] [Abstract][Full Text] [Related]
14. TAFRO Syndrome with Renal Thrombotic Microangiopathy: Insights into the Molecular Mechanism and Treatment Opportunities.
Tu KH; Fan PY; Chen TD; Chuang WY; Wu CY; Ku CL; Tian YC; Yang CW; Fang JT; Yang HY
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208103
[TBL] [Abstract][Full Text] [Related]
15. Membranoproliferative glomerulonephritis-like findings for TAFRO syndrome, associated with an anterior mediastinal tumor: A case report.
Furuto Y; Hashimoto H; Horiuti H; Shibuya Y
Medicine (Baltimore); 2018 Jun; 97(24):e11057. PubMed ID: 29901607
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological features of progressive renal involvement in TAFRO syndrome: A case report and literature review.
Tanaka M; Tsujimoto H; Yamamoto K; Shimoda S; Oka K; Takeoka H
Medicine (Baltimore); 2017 Oct; 96(40):e8216. PubMed ID: 28984775
[TBL] [Abstract][Full Text] [Related]
17. Hepatic Campylobacter jejuni infection in patients with Castleman-Kojima disease (idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome).
Kageyama C; Igawa T; Gion Y; Iwaki N; Tabata T; Tanaka T; Kondo E; Sakai H; Tsuneyama K; Nomoto K; Noguchi H; Yoshino T; Yokota K; Sato Y
Pathol Int; 2019 Oct; 69(10):572-579. PubMed ID: 31631463
[TBL] [Abstract][Full Text] [Related]
18. Renal histology in a patient with TAFRO syndrome: a case report.
Mizuno H; Sekine A; Oguro M; Oshima Y; Kawada M; Sumida K; Yamanouchi M; Hayami N; Suwabe T; Hiramatsu R; Hasegawa E; Hoshino J; Sawa N; Fujii T; Takaichi K; Ohashi K; Ubara Y
Hum Pathol; 2018 Dec; 82():258-263. PubMed ID: 29626596
[TBL] [Abstract][Full Text] [Related]
19. Serial Manifestation of Acute Kidney Injury and Nephrotic Syndrome in a Patient with TAFRO Syndrome.
Ito S; Uchida T; Itai H; Yamashiro A; Yamagata A; Matsubara H; Imakiire T; Shimazaki H; Kumagai H; Oshima N
Intern Med; 2018 Nov; 57(21):3129-3133. PubMed ID: 29877281
[TBL] [Abstract][Full Text] [Related]
20. Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia--a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity?
Masaki Y; Nakajima A; Iwao H; Kurose N; Sato T; Nakamura T; Miki M; Sakai T; Kawanami T; Sawaki T; Fujita Y; Tanaka M; Fukushima T; Okazaki T; Umehara H
J Clin Exp Hematop; 2013; 53(1):79-85. PubMed ID: 23801138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
